The Role of Chemerin in Upper Gastrointestinal Cancer
Metabolites · 07.11.2024 · 14 (11) · 599
DOI: 10.3390/metabo14110599 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 07.11.2024. Verfasst von Adam Mylonakis und 10 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Chemerin, which is a multifunctional cytokine and adipokine, has been implicated in inflammatory and metabolic processes and might play a role in upper gastrointestinal (GI) malignancies, particularly gastric and esophageal cancer. The aim of this review is to explore the role of chemerin in the pathophysiology of upper GI cancers, as well as its potential as a biomarker for early detection and as a therapeutic target.
Methods
A comprehensive review of recent studies about chemerin’s biochemical properties and interaction with its receptors, as well as its effects on inflammatory responses, immune regulation, and metabolic processes, was conducted. The clinical implications of chemerin for gastric and esophageal cancer were analyzed, whereas the potential therapeutic strategies targeting chemerin were discussed.
Results
Elevated chemerin levels are associated with poor prognosis in gastric cancer and promote invasiveness and metastasis in esophageal cancer. Chemerin receptor antagonists show promising results in inhibiting cancer cell migration, invasion, and progression.
Conclusions
Chemerin could represent a valuable prognostic biomarker and therapeutic target for upper GI cancers. Future observational studies should validate its clinical applications and investigate the efficacy of chemerin inhibitors as potential therapeutic targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- First Propaedeutic Department of Surgery, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Environmental, Occupational Medicine and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02139, USA.
- Department of Occupational Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA 02139, USA.
- Department of Oncology, 251 Air Force General Hospital, 11525 Athens, Greece.
ORCID-Profile: Maximos Frountzas, Irene Lidoriki, Eva Karanikki, Dimitrios Schizas
Zitieren
APA
Mylonakis, A., Frountzas, M., Lidoriki, I., Kozadinos, A., Kalfoutzou, A., Karanikki, E., Tsikrikou, I., Kyriakidou, M., Theodorou, D., Toutouzas, K. G., & Schizas, D. (2024). The Role of Chemerin in Upper Gastrointestinal Cancer. Metabolites, 14(11), 599. https://doi.org/10.3390/metabo14110599
Vancouver
Mylonakis A, Frountzas M, Lidoriki I, Kozadinos A, Kalfoutzou A, Karanikki E, et al. The Role of Chemerin in Upper Gastrointestinal Cancer. Metabolites. 2024;14(11):599. doi:10.3390/metabo14110599
BibTeX
@article{Mylonakis2024,
author = {Mylonakis, Adam and Frountzas, Maximos and Lidoriki, Irene and Kozadinos, Alexandros and Kalfoutzou, Areti and Karanikki, Eva and Tsikrikou, Iliana and Kyriakidou, Maria and Theodorou, Dimitrios and Toutouzas, Konstantinos G and Schizas, Dimitrios},
title = {The Role of Chemerin in Upper Gastrointestinal Cancer},
journal = {Metabolites},
year = {2024},
volume = {14},
number = {11},
pages = {599},
doi = {10.3390/metabo14110599}
}
EUVIMED